Cary Street Partners Investment Advisory’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.8K Sell
1,448
-1,942
-57% -$105K 0.01% 569
2026
Q1
$213K Buy
3,390
+1,159
+52% +$92.7K 0.05% 335
2025
Q4
$213K Buy
2,231
+125
+6% +$12.3K 0.06% 314
2025
Q3
$206K Buy
2,106
+103
+5% +$10.7K 0.09% 261
2025
Q2
$215K Sell
2,003
-182
-8% -$18.4K 0.1% 225
2025
Q1
$220K Buy
2,185
+147
+7% +$14.8K 0.13% 197
2024
Q4
$182K Sell
2,038
-17,299
-89% -$1.52M 0.12% 194
2024
Q3
$1.62M Sell
19,337
-681
-3% -$53.7K 0.06% 294
2024
Q2
$1.54M Buy
20,018
+188
+0.9% +$13.8K 0.06% 292
2024
Q1
$1.36M Buy
19,830
+260
+1% +$16.7K 0.06% 300
2023
Q4
$1.13M Buy
19,570
+347
+2% +$18.5K 0.05% 296
2023
Q3
$1.01M Buy
19,223
+1,079
+6% +$56.6K 0.05% 303
2023
Q2
$981K Sell
18,144
-720
-4% -$37.6K 0.06% 259
2023
Q1
$944K Sell
18,864
-53
-0.3% -$2.5K 0.07% 245
2022
Q4
$875K Buy
18,917
+18
+0.1% +$779 0.06% 253
2022
Q3
$732K Buy
18,899
+538
+3% +$21.6K 0.06% 266
2022
Q2
$684K Buy
+18,361
New +$747K 0.06% 260
2020
Q4
Sell
-58
Closed -$2K 420
2020
Q3
$2K Buy
+58
New +$2.23K ﹤0.01% 906

Other funds holding BSX

Cary Street Partners Investment Advisory's BSX Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Boston Scientific (BSX) stake by 57% in Q2 2026, selling an estimated $105K and leaving 1,448 shares worth $61.8K. The position accounts for 0.01% of the portfolio, ranked #569.

Cary Street Partners Investment Advisory first reported a position in BSX in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.62M in Q3 2024. 981 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cary Street Partners Investment Advisory held 1,448 shares of Boston Scientific worth $61.8K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 1,942 Boston Scientific shares in Q2 2026, an estimated $105K.
  • Boston Scientific made up 0.01% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #569 holding.
  • Cary Street Partners Investment Advisory first reported a position in Boston Scientific in Q3 2020 and has held it in 18 quarters since.
  • Cary Street Partners Investment Advisory's Boston Scientific position peaked at $1.62M in Q3 2024.
  • 981 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.